BLT 0.00% 1.7¢ blis technologies limited ordinary shares

Ann: GENERAL: BLT: Health Canada- Approvals for BLIS K12(R) Probiotic

  1. lightbulb Created with Sketch. 2
    • Release Date: 31/07/15 08:31
    • Summary: GENERAL: BLT: Health Canada- Approvals for BLIS K12(R) Probiotic
    • Price Sensitive: No
    • Download Document  2.53KB
    					BLT
    31/07/2015 08:31
    GENERAL
    NOT PRICE SENSITIVE
    REL: 0831 HRS BLIS Technologies Limited
    
    GENERAL: BLT: Health Canada-  Approvals for BLIS K12(R) Probiotic
    
    FOR IMMEDIATE RELEASE
    
    BLIS Technologies and Stratum Nutrition Announce Health Canada
    Approvals for BLIS K12(R) Probiotic
    
    July 30, 2015 (Dunedin, NZ and St. Charles, MO) BLIS Technologies and Stratum
    Nutrition announce new regulatory approvals from Health Canada for use of
    BLIS K12(R) probiotic in supplement products.
    
    Working in partnership, Stratum and BLIS have recently gained Health Canada
    approval that will allow Canadian manufacturers and marketers to make
    substantial and specific label claims on their products which contain the
    BLIS K12 ingredient.
    
    Barry Richardson, CEO of BLIS Technologies, said their strategy of focusing
    on getting through regulatory approvals is a means of opening up markets.
    "As arduous as the process is, each successful regulatory approval prepares
    the ground for the sales and marketing effort that follows."
    
    After reviewing supporting science and safety publications, Health Canada has
    approved products containing BLIS K12 to bear claim language such as, the
    product "promotes oral health [through the re-colonisation of the oral
    cavity]", that it is an "oral probiotic for re-colonisation of the oral
    cavity after antibiotic treatment", that "following oral antimicrobial
    rinsing Streptococcus salivarius K12 supplementation helps reduce volatile
    sulfur compound levels (halitosis)", and that it "can help reduce the
    incidence of
    
    Streptococcal pharyngitis/tonsillitis (sore throats caused by pathogenic
    xvariants belonging to the Streptococcus genus)".
    Kevin J. Ruff, Ph.D., MBA CCRP, Stratum's Director of Scientific & Regulatory
    Affairs said, "Stratum was pleased to be able to use our regulatory expertise
    in North America to open up the Canadian market for BLIS K12 and we expect
    the strong efficacy claims that were approved to really resonate with
    Canadian consumers."
    ###
    
    About Us
    BLIS Technologies is the manufacturer of oral probiotic products based on the
    natural human mouth bacterium Streptococcus salivarius.  Stratum Nutrition is
    the exclusive North American distributor of BLIS probiotic products including
    BLIS K12 and BLIS M18. BLIS K12(R) is a probiotic member of the bacterial
    species Streptococcus salivarius developed in Dunedin, New Zealand for the
    support of oral health.
    For further comment contact:
    Barry Richardson
      021 664 742
    For media assistance contact:
    Heather Thompson       314
    223 7230
    End CA:00267730 For:BLT    Type:GENERAL    Time:2015-07-31 08:31:46
    				
 
watchlist Created with Sketch. Add BLT (NZSX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.